C030:F:F-Lyxor DJ Switzerland Titans 30 (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 169.5

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

851.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.37 (+0.70%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.92 (+0.35%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.59 (-1.01%)

USD 108.41B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.19%)

USD 52.77B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.10 (+0.04%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+0.16 (+0.16%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 46.87B
0ZC:F Zscaler Inc

+11.10 (+4.60%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.35%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.60 (+0.47%)

USD 24.77B

ETFs Containing C030:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.43% 76% C+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.43% 75% C 67% D+
Trailing 12 Months  
Capital Gain 8.18% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.18% 65% D 57% F
Trailing 5 Years  
Capital Gain 53.67% 56% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 53.67% 57% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 8.68% 66% D+ 63% D
Dividend Return 8.68% 63% D 55% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.65% 63% D 90% A-
Risk Adjusted Return 81.55% 81% B- 85% B
Market Capitalization 0.01B 5% F 12% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.